NEUMONÍA POR VIRUS SINCICIAL RESPIRATORIO EN EL ADULTO HOSPITALIZADO : ESTUDIO DE COSTOS DIRECTOS EN DOS HOSPITALES PUBLICOS DE LA CIUDAD DE BUENOS AIRES

Oscar Baloco Espitia; Martin Luis Sivori; Daniel  Pascansky; Fernando Saldarini; Katerine Ortuño; Verónica Pascuchelli

doi:10.56538/ramr.NWOD6235

Authors

Oscar Baloco Espitia Pulmonology University Center, “Dr.J.M.Ramos Mejía”, Faculty of Medicine, University of Buenos Aires, Pulmonology and Tisiology Unit, “Hospital Dr. J. M. Ramos Mejía.” City of Buenos Aires https://orcid.org/0009-0003-8684-2523
Martin Luis Sivori Pulmonology University Center, “Dr.J.M.Ramos Mejía”, Faculty of Medicine, University of Buenos Aires, Pulmonology and Tisiology Unit, “Hospital Dr. J. M. Ramos Mejía.” City of Buenos Aires. https://orcid.org/0000-0001-5995-2856
Daniel Pascansky Pulmonology University Center, “Dr.J.M.Ramos Mejía”, Faculty of Medicine, University of Buenos Aires, Pulmonology and Tisiology Unit, “Hospital Dr. J. M. Ramos Mejía.” City of Buenos Aires. https://orcid.org/0000-0002-3009-1615
Fernando Saldarini Pulmonology and Tisiology Section, Hospital Donación “José Santojanni”, City of Buenos Aires https://orcid.org/0000-0003-0337-2443
Katerine Ortuño Pulmonology and Tisiology Section, Hospital Donación “José Santojanni”, City of Buenos Aires https://orcid.org/0009-0004-5300-8804
Verónica Pascuchelli Central Laboratory Department, Molecular Biology Section, Hospital “Dr. J. M. Ramos Mejía.” City of Buenos Aires. https://orcid.org/0009-0000-7782-7776

DOI:

https://doi.org/10.56538/ramr.NWOD6235

Keywords:

Virus Sincicial Respiratorio, neumonia, hospitalizaciones, costo directo, gastos

Abstract

Introduction: There are no studies on costs associated with hospitalization in adults with respiratory syncytial virus (RSV) infection in Argentina.
Objective: To determine the direct cost structure of adults hospitalized for RSV in public hospitals in the Autonomous City of Buenos Aires (CABA).
Materials and Methods: Patients >18 years hospitalized for RSV infection from January-June 2024 in two Public Hospitals of CABA. Comparisons were made between < and > 60 years.
Diagnosis: viral panel (PCR) positive only for RSV. Direct costs were determined from the payer’s perspective. Hospitalization modulation was carried out by the CABA Government as of June 2024, official exchange rate parity 9.18 pesos/dollar (sale).
Results: 18 patients were enrolled, mean age 65 years (IQR 48.2-79.2); 56 % smokers with high comorbidity burden. Three patients were in the Intensive Care Unit (16.6 %); Fatal case rate: 27.7%. The direct cost was 5278.88 dollars/patient (IQR 2932.8-11,131.1) and the total direct cost was 195202.33 dollars/all patients. Comparing > and < 60 years, the former showed 63 % higher direct costs and a higher fatal case rate (34.4 % vs 0 %).
Conclusion: The majority of patients hospitalized for RSV infection are 65 years old with comorbidities, smoking, and high lethality. The direct cost from the payer’s perspective was 5278.88 dollars/patient. The total direct cost was 195,202.33 dollars/all patients. Patients >60 years had higher direct hospitalization costs and lethality. This is the first study in Argentina on direct costs for RSV infection in hospitalized adults in public hospitals.